FDA grants orphan drug exclusivity to Spectrum Pharmaceutical's Evomela(tm)
Thursday, April 21, 2016
Spectrum Pharmaceuticals Inc FDA grants orphan drug exclusivity to Evomela(tm) (melphalan) for injection, indicated for multiple myeloma.
Spectrum Pharmaceuticals Inc says Evomela has also been recently listed in orange book.
Source : reuters.com
